S Huege); Health-related College of Wisconsin, Milwaukee, WI (Dr P Antuono
S Huege); Healthcare College of Wisconsin, Milwaukee, WI (Dr P Antuono); Oregon Well being and Science University Aging and Alzheimer Disease Center, Portland, OR (Dr J Quinn); Byrd Alzheimer’s Institute Tampa, FL (Dr A Raj); Caspase 9 Inhibitor Purity & Documentation Collier Neurologic Specialists, Naples, FL (Dr M Baker); University of Kansas Medical Center Division of Neurology, Kansas City, KS (Dr J Burns); Kylynych Center for Memory Cognition Study, Wake Forest University Wellness Sciences, Winston-Salem, NC (Dr K Sink); California Healthcare Clinic for Headache, Santa Monica, CA (Dr D Kudrow); Alzheimer’s Analysis Corporation, Manchester, NY (Dr J Shua-Haim); University Hills Clinical Analysis, Irvine, CA (Dr MA Knisevich); Behavioral Medical Analysis of Staten Island, NY (Dr J Breving); Collaborative Neuroscience Network, Garden Grove, CA (Dr O Omidvar); Clinical Trials of America Inc., Winston-Salem, NC (Dr B Jones); Radiant Research, Denver, CO (Dr E Duboff); Clinical Study Center of Asheville LLC, Asheville, NC (Dr C Tuten); Suncoast Neuroscience Associates Inc., St. Petersburg, FL (Dr S Cohen); Bradenton Investigation Center, Bradenton, FL (Dr W McElveen); Lynn Overall health Science Institute, Oklahoma City, OK (Dr S Randhawa); Radiant Analysis, San Antonio, TX (Dr T Weiss); Fort Wayne Neurological Center, Fort Wayne, IN (Dr F-L Chang); University of Kentucky Health-related Center, Sanders-Brown Center on Aging, Lexington, KY (Dr G Jicha); Agewell Indianapolis, IN (Dr S Rappaport); Premiere Investigation Institute, West Palm Beach, FL (Dr C Sadowsky and Dr T Villena); Healthcare University of South Carolina, Clinical Biotechnology Investigation Institute, Roper St. Francis Healthcare, and Ralph H. Johnson VA Medical Center, North Charleston, SC (Dr J Mintzer); Radiant Analysis Inc., Chicago, IL (Dr M Kyle); Synergy Clinical Analysis Center, Calcium Channel Antagonist medchemexpress National City, CA (Dr M Bari); San Francisco Clinical Study Center, San Francisco, CA (Dr J Goldstein); Wake Research Associates LLC, Raleigh, NC (Dr A Jariwala); Beacon Clinical Analysis LLC, Brockton, MA (Dr P Sergi); Drexel University College of Medicine Department of Neurology, Philadelphia, PA (Dr C Lippa); Meridien Study, Brooksville, FL (Dr M Farmer); Meridien Analysis, St. Petersburg, FL (Dr G Lefebvre); Northeastern Pennsylvania Memory Alzheimer’s Center, Plains, PAConclusion This S-Connect clinical trial establishes the fact that Souvenaid as an add-on intervention doesn’t slow general cognitive decline and is secure and properly tolerated in persons with mild-to-moderate AD working with AD medication. Added fileAdditional file 1: Table S1. Presenting the nutritional composition of Souvenaid and manage solution. Abbreviations AD: Alzheimer’s illness; ADAS-cog: Alzheimer’s Disease Assessment Scale Cognitive Subscale; MMSE: Mini-Mental State Examination; SD: Common deviation. Competing interests Study design and preparing were carried out in conjunction using the sponsor, Nutricia Analysis, on behalf of Nutricia Sophisticated Medical Nutrition. The sponsor also provided the study items and funding for the analysis, information collection and analysis. The corresponding author had final responsibility for the selection to submit for publication. RCS serves on the Board of Directors on the Alzheimer’s Association Greater Illinois Chapter; serves as a member from the Investigator Consultation Network for Merck Investigation Laboratories; served on a investigation advisory panel for Accera, Inc., in addition to a clinical advisory panel for Nutricia, Inc.; receives or not too long ago received research.
